US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Health Care Select Sector SPDR Fund

167.66

-0.0900-0.05%

Pre-market: 167.670.0100+0.01%09:07 EDT

Volume:7.43M

Turnover:1.24B

Market Cap:43.54B

PE:-11.79

High:168.20

Open:167.79

Low:166.18

Close:167.75

52wk High:176.60

52wk Low:133.73

Shares:259.67M

Float Shares:259.67M

Volume Ratio:0.86

T/O Rate:2.86%

Dividend:2.53

Dividend Rate:1.51%

EPS(TTM):-14.2170

EPS(LYR):-14.2170

ROE:-9.22%

ROA:1.03%

PB:1.27

PE(LYR):-11.79

Loading ...

Overview Company News Filings

Eli Lilly Stock (LLY) Gets a Bullish Note from JPMorgan Chase

Analysts’ Top Healthcare Picks: Dogwood Therapeutics (DWTX), Quoin Pharmaceuticals (QNRX)

Sector Update: Healthcare Stocks Higher Thursday Afternoon

MT Newswires Live

Healthcare Stocks Pick up Steam as Investors Play Offense and Defense

Eisai’s Lenvima Combo Trial in Liver Cancer Ends With Mixed but Market-Relevant Results

Health Care Roundup: Market Talk

Summit Therapeutics Says it is Beating Merck with Its Cancer Drug

Analysts’ Top Healthcare Picks: Align Tech (ALGN), Eledon Pharmaceuticals (ELDN)

Spire Healthcare grants Toscafund brief extension on potential 250p-per-share bid

Analysts’ Top Healthcare Picks: uniQure (QURE), Alumis Inc. (ALMS)

Analysts Are Bullish on Top Healthcare Stocks: Revolution Medicines (RVMD), Teva Pharmaceutical (TEVA)

AbbVie's Phase 3 Study of Etentamig in Multiple Myeloma Meets Dual Primary Endpoints

MT Newswires Live

AbbVie Says Blood Cancer Drug Met Dual Primary Endpoints in Phase 3 Study

J.P. Morgan’s Salveen Richter Reiterates Buy on Teva, Citing TEV-408 Phase 2a Success and Pipeline-in-a-Product Potential

AbbVie announces Phase 3 Cervino study met dual primary endpoints of ORR, PFS

AbbVie's Blood Cancer Drug Meets Late-Stage Trial Goals

Abbvie - Phase 3 Cervino Study Met Dual Primary Endpoints; Full Results to be Presented Sept 23-26

THOMSON REUTERS

Abbvie - Etentamig Demonstrates Low Rates of Cytokine Release Syndrome and Fatal Infections

THOMSON REUTERS

Abbvie - Etentamig Achieves 74% Orr and 60% Risk Reduction in Phase 3 Cervino Trial

THOMSON REUTERS

Abbvie Announces Positive Topline Results from the Phase 3 Cervino Trial Showing Etentamig Significantly Improved Response Rate and Progression-Free Survival in Patients with Relapsed/Refractory Multiple Myeloma

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.imtigers.com/stock/XLV/news?page=23"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"XLV","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"XLV\",,,,,undefined,":{"symbol":"XLV","market":"US","secType":"STK","nameCN":"Health Care Select Sector SPDR Fund","latestPrice":167.66,"timestamp":1789502400000,"preClose":167.75,"halted":0,"volume":7429016,"hourTrading":{"tag":"盘前","latestPrice":167.67,"preClose":167.66,"latestTime":"09:07 EDT","volume":2014,"amount":338271.11776000005,"timestamp":1789564075275,"change":0.01,"changeRate":0.00006,"amplitude":0.00679},"delay":0,"changeRate":-0.000536512667660229,"floatShares":259665324,"shares":259665324,"eps":-14.217021,"marketStatus":"Pre-Mkt","change":-0.09,"latestTime":"09-16 09:09:32 EDT","open":167.79,"high":168.2,"low":166.1783,"amount":1242886857.54688,"amplitude":0.012052,"askPrice":168.14,"askSize":1,"bidPrice":167.4,"bidSize":2,"shortable":3,"etf":1,"ttmEps":-14.217021,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1789565400000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":167.66,"sharesOutstanding":265215324,"nav":167.716534,"aum":43566939827.04,"dividendRate":0.0151,"bidAskSpread":0.000107,"preHourTrading":{"tag":"盘前","latestPrice":167.67,"preClose":167.66,"latestTime":"09:07 EDT","volume":2014,"amount":338271.11776000005,"timestamp":1789564075275,"change":0.01,"changeRate":0.00006,"amplitude":0.00679},"postHourTrading":{"tag":"盘后","latestPrice":167.9,"preClose":167.66,"latestTime":"19:48 EDT","volume":290838,"amount":48762008.102,"timestamp":1789516088152,"change":0.24,"changeRate":0.001431,"amplitude":0.001431},"volumeRatio":0.8649652545308526,"impliedVol":0.1802,"impliedVolPercentile":0.544},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"XLV\",,,,,undefined,":{"symbol":"XLV","floatShares":259665324,"roa":"1.03%","roe":"-9.22%","lyrEps":-14.217021,"volumeRatio":0.8649652545308526,"shares":259665324,"dividePrice":2.5317,"high":168.2,"amplitude":0.012052,"preClose":167.75,"low":166.1783,"week52Low":133.725,"pbRate":"1.27","psRate":"66.09","week52High":176.595,"institutionHeld":0.7846,"latestPrice":167.66,"committee":0.333333,"eps":-14.217021,"divideRate":0.0151,"volume":7429016,"delay":0,"ttmEps":-14.217021,"open":167.79,"prevYearClose":154.8,"prevWeekClose":165.36,"prevMonthClose":170.54,"prevQuarterClose":158.66,"fiveDayClose":167.13,"twentyDayClose":167.05,"sixtyDayClose":149.4},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/XLV\",params:#limit:5,,,undefined,":[{"date":"2026-06-22","symbol":"XLV","amount":0.656252,"announcedDate":"2026-06-18","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-22","defaultRemindTime":1782135000000,"name":"健康照护类股ETF-SPDR","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-24","payableDate":"2026-06-22","currency":"USD","dateTimestamp":1782100800000,"payDate":"2026-06-24"},{"date":"2026-03-23","symbol":"XLV","amount":0.59468,"announcedDate":"2026-03-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-23","defaultRemindTime":1774272600000,"name":"健康照护类股ETF-SPDR","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-25","payableDate":"2026-03-23","currency":"USD","dateTimestamp":1774238400000,"payDate":"2026-03-25"},{"date":"2025-12-22","symbol":"XLV","amount":0.656822,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"健康照护类股ETF-SPDR","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-24","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-24"},{"date":"2025-09-22","symbol":"XLV","amount":0.624868,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"健康照护类股ETF-SPDR","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-24","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-24"},{"date":"2025-06-23","symbol":"XLV","amount":0.630382,"announcedDate":"2025-06-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-23","defaultRemindTime":1750685400000,"name":"健康照护类股ETF-SPDR","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-25","payableDate":"2025-06-23","currency":"USD","dateTimestamp":1750651200000,"payDate":"2025-06-25"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"XLV\",market:\"US\",,,undefined,":[{"executeDate":"2016-09-16","recordDate":"2016-09-20","paymentDate":"2016-09-26","value":0.278502,"currency":"USD"},{"executeDate":"2016-12-16","recordDate":"2016-12-20","paymentDate":"2016-12-27","value":0.305416,"currency":"USD"},{"executeDate":"2017-03-17","recordDate":"2017-03-21","paymentDate":"2017-03-27","value":0.273839,"currency":"USD"},{"executeDate":"2017-06-16","recordDate":"2017-06-20","paymentDate":"2017-06-26","value":0.307823,"currency":"USD"},{"executeDate":"2017-09-15","recordDate":"2017-09-18","paymentDate":"2017-09-25","value":0.304755,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"XLV\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"XLV\",pageSize:20,pageCount:23,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2664809829","title":"Eli Lilly Stock (LLY) Gets a Bullish Note from JPMorgan Chase","url":"https://stock-news.laohu8.com/highlight/detail?id=2664809829","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664809829?lang=en_us&edition=fundamental","pubTime":"2026-09-04 02:48","pubTimestamp":1788461317,"startTime":"0","endTime":"0","summary":"JPMorgan Chase ($JPM) is pounding the table on the stock of pharmaceutical giant Eli Lilly ($LLY) as sales of its weight-loss drugs accelerate. Chr...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/eli-lilly-stock-lly-gets-a-bullish-note-from-jpmorgan-chase?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/eli-lilly-stock-lly-gets-a-bullish-note-from-jpmorgan-chase?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2471134952.CNY","LU0265550359.USD","LU0157215616.USD","SG9999015952.SGD","IE00BJLML261.HKD","LU0820562030.AUD","IE00B1XK9C88.USD","LU1979441026.SGD","SGXZ81514606.USD","LU0345769128.USD","IE00BK4W5M84.HKD","LU0158827781.USD","LU0267386448.USD","LU2468319806.SGD","LU1093756325.SGD","FTXH","LU2108987350.USD","LU1032466523.USD","LU2237443465.HKD","LU0310799852.SGD","LU0882574139.USD","SG9999002224.SGD","WDNA","LU0256863902.USD","VFH","BK4581","LU1127390331.HKD","LU0456855351.SGD","LU0158827948.USD","IYG","LU0964807845.USD","PPH","SG9999002232.USD","LU0225283273.USD","SGXZ57979304.SGD","LU0432979614.USD","LU1914381329.SGD","LU2023251221.USD","LU1145028129.USD","LU2430703095.HKD","XLF","ELIS","ILDR","LU2361044949.HKD","LU1023059063.AUD","LU0109394709.USD","LU1551013425.SGD","LU1496350171.SGD","IE00BN29S564.USD","MHIP","IE00BBT3K403.USD","LU1868836591.USD","LLY","LU2602419157.SGD","LU0471298777.SGD","IE00BKDWB100.SGD","IE00B775SV38.USD","LU0320765646.SGD","LU0211326839.USD","IE00BLSP4452.SGD","LU0823434583.USD","LU2462591350.SGD","LU2746668974.SGD","LU1894683348.USD","LU2471134523.USD","LU2112291526.USD","LU2237443978.SGD","LU0203345920.USD","LU1814569148.SGD","LU1116320737.USD","IE00BWXC8680.SGD","LU2491049909.HKD","LU0971096721.USD","IE0005OL40V9.USD","SG9999018857.SGD","SGXZ51526630.SGD","IE00B775H168.HKD","LU0170899867.USD","LU0149725797.USD","IE0004445015.USD","LU2360106947.USD","GB00BDT5M118.USD","IE0034235303.USD","LU1267930730.SGD","LU2054465674.USD","LU2357305700.SGD","IE00BKPKM429.USD","IE00B3S45H60.SGD","IE00BFSS8Q28.SGD","LU2023250504.SGD","LU0079474960.USD","LU1983299246.USD","LU0354030511.USD","LLYZ","LU0976567544.SGD","IE00BJTD4N35.SGD","JPMO","LU2242649171.HKD","LU0048584097.USD","LU0466842654.USD","IE00BFXG1179.USD","IE00BJJMRY28.SGD","BK4207","LU2491050154.USD","LLYX","LU0942090050.USD","LU0708995401.HKD","LU0345770308.USD","LU1244550577.SGD","LU0109391861.USD","LU2750360641.GBP","GDOC","LU0198837287.USD","IE00BJJMRZ35.SGD","LU0820561909.HKD","LU1162221912.USD","IE00BJTD4V19.USD","LU0211331839.USD","LU2023250330.USD","LU0640476718.USD","LU2461242641.AUD","LU2430703178.SGD","TMED","IE00B7KXQ091.USD","IE00BN8TJ469.HKD","LU0210536198.USD","IXJ","MEDX","LU1323610961.USD","TRUF","LU2106854487.HKD","LU2264538146.SGD","LU2324357040.USD","LU0354030438.USD","LU0316494557.USD","LU0122379950.USD","LU1267930490.SGD","LU0133085943.USD","LU0203201768.USD","SG9999018865.SGD","LU1496350502.SGD","LU0187121727.USD","LU1061106388.HKD","LU0787776722.HKD","SGXZ31699556.SGD","LU0786609619.USD","LU2357627491.SGD","LU2456880835.USD","IE0009355771.USD","LU2168564222.USD","LU2237438978.USD","LU0094547139.USD","LU0234572021.USD","LU0203202063.USD","ELIL","LU1244550494.USD","LU2023250843.SGD","LU2552382132.HKD","LU0943347566.SGD","LU1989771016.USD","LLII","SG9999001176.SGD","LU1093756168.USD","LU0238689110.USD","IE00B1BXHZ80.USD","LU2756315664.SGD","JPM","LU1670628061.USD","LU1668664300.SGD","LU1366333091.USD","LU2237443382.USD","TRUH","OZEM","LU1366192091.USD","BK4599","LU1712237335.SGD","LU1119994496.HKD","LU1894683264.USD","IE00B4R5TH58.HKD","LU0106831901.USD","LU0385154629.USD","LU0353189680.USD","LU0251132253.USD","LU0889565916.HKD","LU1261432733.SGD","IE00BK4W5L77.USD","IE00BHPRN162.USD","IE00BLSP4239.USD","FHLC","BK4585","LU2237443895.HKD","LU2168563687.JPY","IE00BDRTCR15.USD","IE0004445239.USD","LU0096364046.USD","LU2471134879.HKD","LU0006306889.USD","LU0345770993.USD","LU2592432038.USD","LU0174119429.USD","LU0820561818.USD","LU1623119135.USD","BK4534","LU1629891620.HKD","IE00B2B36J28.USD","IE00B4JS1V06.HKD","LU1035775433.USD","LU1232071149.USD","BK4504","FTXO","LU0256863811.USD","IE0002141913.USD","LU2381873111.SGD","LU0061475181.USD","LU0070302665.USD","BK4516","LU0868494708.USD","LU2417539215.USD","LU2756315318.SGD","SG9999014880.SGD","TFNS","LU2896262040.SGD","LU2271345857.HKD","LU2089284900.SGD","IE0034235188.USD","LU1691799644.USD","LU1363072403.SGD","IE0001KFT4U8.USD","IE00BFTCPJ56.SGD","LU2168564149.EUR","SG9999013999.USD","LU0496365809.HKD","LU1988902786.USD","LU1868836914.USD","IYH","SGXZ99366536.SGD","LU1057294990.SGD","LU1868837300.USD","LU0345769631.USD","LU2063271972.USD","LU1069344957.HKD","LU2505996509.AUD","PJP","LU0211327993.USD","LU0672654240.SGD","SG9999015978.USD","LU0689472784.USD","LU2750360997.AUD","IYF","IE00BFSS7M15.SGD","LU2361045086.USD","LU1548497426.USD","SG9999015986.USD","LU1868836757.USD","IXG","LU0859254822.USD","LU0323591593.USD","AGNG","LU0823434740.USD","LU1720051017.SGD","LU2087625088.SGD","BK4550","LU0320765992.SGD","CANC","LU2236285917.USD","LU2552382058.USD","LU1116320901.HKD","LU2111349929.HKD","LU0683600562.USD","LU0234570918.USD","LU0320765059.SGD","LU1291159041.SGD","THNR","LU0211326755.USD","LU0215105999.USD","IE00BZ1G4Q59.USD","LU2028103732.USD","LU0106261372.USD","LU2089283258.USD","IE00BDCRKT87.USD","IE0034235295.USD","FNCL","LU2552382215.SGD","SG9999014914.USD","IE00BJJMRX11.SGD","LU0114720955.EUR","LU2237443622.USD","HRTS","LU1280957306.USD","SG9999015945.SGD","LU0265550946.USD","LU0882574055.USD","CURE","LU0417517546.SGD","LU1084165304.USD","LU0289739699.SGD","LU2361044865.SGD","MEDI","LU2213496289.HKD","LU0097036916.USD","BK4588","LU0823416689.USD","LU1720051108.HKD","BK4533","IE00BKVL7J92.USD","JDOC","LU2211815571.USD","LU0266013472.USD","LU2168564065.EUR","LU0203347892.USD","LU0211328371.USD","LU1551013342.USD","LU0208291251.USD","LU1974910355.USD","LU2491050071.SGD","LU2265009873.SGD","LU2089984988.USD","SG9999001176.USD","SG9999014898.SGD","SG9999014906.USD","LU0471298694.HKD","LU2237443549.SGD","LU1244550221.USD","XLV","KBWB","LU2471134796.USD","IHE","LU0058720904.USD","LU0353189763.USD","LU2746668461.USD","LU1064131342.USD","LU1670627923.USD","LU2168564495.EUR","LU1804176565.USD","RXL","LU2505996681.GBP","JPO","BK4007","LU2244417387.USD","LU1917777945.USD","UYG","IE000M9KFDE8.USD","IE00BJT1NW94.SGD","LU0320765489.SGD","SG9999017495.SGD","VHT","IE00BYXW3230.USD","BK4566","LU1868837136.USD","LU2430703251.USD","LU0868494617.USD","LU2462157665.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664806777","title":"Analysts’ Top Healthcare Picks: Dogwood Therapeutics (DWTX), Quoin Pharmaceuticals (QNRX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2664806777","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664806777?lang=en_us&edition=fundamental","pubTime":"2026-09-04 02:30","pubTimestamp":1788460208,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Dogwood Therapeutics (DWTX) and Quoin Pharmaceutical...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-dogwood-therapeutics-dwtx-quoin-pharmaceuticals-qnrx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-dogwood-therapeutics-dwtx-quoin-pharmaceuticals-qnrx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","LU0128526141.USD","BK4581","XLV","LU0029874061.USD","XBI","DWTX","QNRX","BK4137","LABU","BK4139","BK4585","HCSG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664080500","title":"Sector Update: Healthcare Stocks Higher Thursday Afternoon","url":"https://stock-news.laohu8.com/highlight/detail?id=2664080500","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664080500?lang=en_us&edition=fundamental","pubTime":"2026-09-04 01:49","pubTimestamp":1788457760,"startTime":"0","endTime":"0","summary":"Healthcare stocks were slightly higher Thursday afternoon, with the NYSE Healthcare Index increasing 0.3% and the State Street Health Care Select Sector SPDR ETF  up 0.1%.The iShares Biotechnology ETF  eased 0.3%.In corporate news, Hutchmed  shares jumped 17% after the company said its unit licensed rights to GSK  to develop and commercialize experimental cancer treatment HMPL-A830 outside greater China. GSK shares added 0.8%.AbbVie  said Thursday that it has completed its acquisition of Apogee Therapeutics , valuing the clinical-stage biotechnology company at about $10.9 billion, or $135.11 per share. AbbVie shares were down 0.3%.Ultragenyx Pharmaceutical  shares fell 45% after the firm said a phase 3 study of apazunersen in Angelman syndrome did not achieve the primary endpoint nor a key secondary endpoint.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1496350171.SGD","LU0708994859.HKD","GLAM","LU1244550577.SGD","IE00B4R5TH58.HKD","LU0820561909.HKD","PJP","IXJ","VHT","MEDX","BK4137","LABU","LU1989772923.USD","FTXH","LU0029864427.USD","ABBV","LU0289961442.SGD","GSKH","LU0203345920.USD","SBIO","LU0128525929.USD","XBI","FHLC","LU1718418525.SGD","GSK.UK","IBB","XLV","LU0553294199.USD","HCM","IE0004445239.USD","IE00BGHQF631.EUR","IE00BJJMRZ35.SGD","LU1236620750.USD","PPH","IYH","HCSG","LU0432979614.USD","LU2237443382.USD","LU0114720955.EUR","AGNG","TRUH","APGE","RXL","BK4534","LU2125909593.SGD","LU0124676726.USD","GSK","LU0256863811.USD","RARE","JDOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664880504","title":"Healthcare Stocks Pick up Steam as Investors Play Offense and Defense","url":"https://stock-news.laohu8.com/highlight/detail?id=2664880504","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664880504?lang=en_us&edition=fundamental","pubTime":"2026-09-04 01:39","pubTimestamp":1788457140,"startTime":"0","endTime":"0","summary":"Want a prescription for investing success?","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2552382215.SGD","IE0002141913.USD","LU0823434740.USD","LU2750360641.GBP","IE00BN29S564.USD","LU2237443622.USD","IE00BKPKM429.USD","LU2023250504.SGD","LABU","LU2111349929.HKD","LU1023059063.AUD","LLY","LU1720051017.SGD","LU1868836591.USD","SG9999015978.USD","LU1057294990.SGD","LU1988902786.USD","BK4532","LU2237438978.USD","XLV","IDNA","MHIP","IE00BWXC8680.SGD","IE00B4JS1V06.HKD","LU2264538146.SGD","LU1691799644.USD","LU0640476718.USD","RXL","LU2361045086.USD","LU0672654240.SGD","GB00BDT5M118.USD","LU1127390331.HKD","LU0106261372.USD","IE00BKDWB100.SGD","LU0823416689.USD","LU2756315664.SGD","SGXZ57979304.SGD","LU0109394709.USD","LU2213496289.HKD","LU1280957306.USD","SGXZ51526630.SGD","LU0266013472.USD","BK4568","LU2265009873.SGD","LU2552382132.HKD","SG9999018857.SGD","MEDX","LU0061475181.USD","LU2112291526.USD","LU0417517546.SGD","LU1868836757.USD","MRNX","SG9999015952.SGD","SGXZ31699556.SGD","BK4548","IE00B4R5TH58.HKD","LU0882574139.USD","IE00BJT1NW94.SGD","THNR","LU2471134879.HKD","LU0882574055.USD","LU1917777945.USD","LU0316494557.USD","AGNG","SG9999015945.SGD","BK4501","LU0820562030.AUD","LLYX","LU1712237335.SGD","LU0122379950.USD","FTXH","LU1979441026.SGD","LU1868836914.USD","LU2471134796.USD","JDOC","WDNA","LU0079474960.USD","LU2089984988.USD","LU1868837136.USD","LU2462591350.SGD","LU0787776722.HKD","LU2471134523.USD","LU1868837300.USD","ELIS","LU0964807845.USD","IE00BK4W5M84.HKD","MRNA","LU2237443465.HKD","PPH","TMED","LU1983299246.USD","LU2361044865.SGD","IE0005OL40V9.USD","LU1551013425.SGD","SG9999014906.USD","LU0238689110.USD","IE00BJLML261.HKD","LU0210536198.USD","BK4599","IE00BFSS7M15.SGD","LU0786609619.USD","LU1232071149.USD","LLII","SG9999015986.USD","SG9999018865.SGD","LU2063271972.USD","LU0174119429.USD","LU0345770993.USD","LU0466842654.USD","LU2168564065.EUR","LU2168564222.USD","LU0256863811.USD","LU2023250330.USD","IE0004445015.USD","BK4139","LU1093756168.USD","LU2168563687.JPY","IE0009355771.USD","LU2023251221.USD","IE00BJJMRX11.SGD","LU0203202063.USD","LU0354030438.USD","LU0006306889.USD","LU0158827948.USD","LU0133085943.USD","LU0353189763.USD","LU2456880835.USD","LU2468319806.SGD","LU0432979614.USD","SG9999013999.USD","SGXZ99366536.SGD","TRUH","LU0385154629.USD","LU2361044949.HKD","SG9999001176.USD","LU0094547139.USD","LU0225283273.USD","LU2746668461.USD","LU0158827781.USD","BK4534","LU2106854487.HKD","LU2324357040.USD","LU0471298694.HKD","LU1064131342.USD","GNOM","LU1323610961.USD","LU1548497426.USD","LU2360106947.USD","LU2896262040.SGD","IE00B7KXQ091.USD","LU1804176565.USD","GDOC","LU0203201768.USD","LU1035775433.USD","LU2462157665.USD","LU0323591593.USD","LU2417539215.USD","LU2602419157.SGD","LU1989771016.USD","LU2491050071.SGD","LGHT","LU0820561909.HKD","LU1814569148.SGD","LU2237443382.USD","BK4588","IHE","MRNY","LU2491050154.USD","LU2087625088.SGD","LU0820561818.USD","IE00B1BXHZ80.USD","IE00BK4W5L77.USD","IE00BJJMRZ35.SGD","SGXZ81514606.USD","LU0353189680.USD","IE00B775H168.HKD","LU0683600562.USD","LU2237443978.SGD","XBI","LU2750360997.AUD","LU1291159041.SGD","LU0889565916.HKD","LU2028103732.USD","ELIL","LU0096364046.USD","LU0234572021.USD","IE00B2B36J28.USD","LU1061106388.HKD","FHLC","SG9999017495.SGD","LU2236285917.USD","LU1974910355.USD","LU0345770308.USD","BK4585","LU0198837287.USD","BK4581","SG9999014880.SGD","LU0097036916.USD","LLYZ","CANC","LU0320765059.SGD","LU0114720955.EUR","LU0354030511.USD","LU0471298777.SGD","LU0708995401.HKD","LU1366192091.USD","LU2237443549.SGD","PJP","BK4007","LU2271345857.HKD","IE0001KFT4U8.USD","LU2471134952.CNY","MEDI","OZEM","LU0320765992.SGD","LU2746668974.SGD","LU1551013342.USD","ILDR","LU2552382058.USD","SG9999001176.SGD","LU2756315318.SGD","BK4533","LU0289739699.SGD","IBB","LU0456855351.SGD","SG9999014898.SGD","IE00B1XK9C88.USD","IE00BJJMRY28.SGD","LU2108987350.USD","BK4516","LU1093756325.SGD","LU1720051108.HKD","IE0004445239.USD","LU2461242641.AUD","HRTS","LU2357305700.SGD","LU1267930730.SGD","LU2089284900.SGD","LU2491049909.HKD","LU0943347566.SGD","LU2211815571.USD","IE00BFTCPJ56.SGD","LU2237443895.HKD","LU0058720904.USD","LU2089283258.USD","IE00BFSS8Q28.SGD","LU0109391861.USD","LU0256863902.USD","LU0823434583.USD","LU1623119135.USD","LU1069344957.HKD","SG9999014914.USD","LU2168564149.EUR","LU0689472784.USD","LU1145028129.USD","LU1629891620.HKD","BK4551","LU2168564495.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664805360","title":"Eisai’s Lenvima Combo Trial in Liver Cancer Ends With Mixed but Market-Relevant Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2664805360","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664805360?lang=en_us&edition=fundamental","pubTime":"2026-09-04 00:30","pubTimestamp":1788453049,"startTime":"0","endTime":"0","summary":"Eisai Co ($ESALF) announced an update on their ongoing clinical study. The Phase 3 LEAP-012 study, run by Merck Sharp & Dohme with Eisai as partner...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/eisais-lenvima-combo-trial-in-liver-cancer-ends-with-mixed-but-market-relevant-results?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/eisais-lenvima-combo-trial-in-liver-cancer-ends-with-mixed-but-market-relevant-results?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1201861249.SGD","BK4588","FHLC","GDOC","IE00B4R5TH58.HKD","XLV","LU2468319806.SGD","LU1934455863.HKD","LU0477156953.USD","LU0859254822.USD","LU2360032135.SGD","BK4007","LU2361044865.SGD","SG9999001176.SGD","LU1974910355.USD","HRTS","IXJ","VHT","TRUH","BMED","RXL","IYH","LU0238689110.USD","LU2125909247.SGD","IHE","FTXH","LU1989771016.USD","PPH","MRK","LU2357627491.SGD","LU0868494617.USD","LU1057294990.SGD","LU0320765489.SGD","IE00BN8TJ469.HKD","LU0265550359.USD","LU2125154778.USD","IE00BLSP4239.USD","IE0009355771.USD","JDOC","BK4550","SG9999002224.SGD","LU1585245621.USD","LU1037948897.HKD","PAWZ","LU1061106388.HKD","LU0124676726.USD","LU0211331839.USD","SG9999015358.SGD","BK4585","LU0208291251.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664030948","title":"Health Care Roundup: Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2664030948","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664030948?lang=en_us&edition=fundamental","pubTime":"2026-09-04 00:20","pubTimestamp":1788452400,"startTime":"0","endTime":"0","summary":"The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET.0810 ET - AstraZeneca's new drug for chronic obstructive pulmona","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XBI","XLV","BK4585","BK4581","BK4588","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664031788","title":"Summit Therapeutics Says it is Beating Merck with Its Cancer Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2664031788","media":"Dow Jones","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664031788?lang=en_us&edition=fundamental","pubTime":"2026-09-04 00:00","pubTimestamp":1788451200,"startTime":"0","endTime":"0","summary":"Shares of the drug developer Summit Therapeutics were up more than 12% Thursday morning on news that its drug is performing well in a Chinese lung cancer study.Summit stock jumped to $16.46 after the ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1974910355.USD","LU0868494708.USD","LU0648001328.SGD","LU1066051225.USD","LU2488822045.USD","TRUH","IE00BJJMRZ35.SGD","IE0009355771.USD","LU1430594728.SGD","LU0122379950.USD","IHE","LU1941712348.USD","LU0985320562.USD","LU0006306889.USD","LU1989772923.USD","LU1069347547.HKD","LU0980610538.SGD","BK4516","LU2433249047.HKD","LU2112291526.USD","LU0203345920.USD","LU0965509101.SGD","BK4588","LU1037948897.HKD","LU1917777945.USD","LU0130517989.USD","LU0823416689.USD","SG9999001440.SGD","HRTS","LU0208291251.USD","LU2023250843.SGD","LU2491049909.HKD","IE000M9KFDE8.USD","LU2089984988.USD","SG9999001176.SGD","IYH","LU1093756168.USD","IE00B1BXHZ80.USD","LU2324357040.USD","IXJ","SG9999014567.USD","IE00B2B36J28.USD","LU0942090050.USD","SG9999002224.SGD","IE00B4R5TH58.HKD","LU1934455277.USD","LU1066051498.USD","LU0130102774.USD","LU1989771016.USD","LU0265550359.USD","LU2360032135.SGD","LU0058720904.USD","PAWZ","LU0124676726.USD","BK4585","FHLC","LU2023250504.SGD","GDOC","SG9999014575.USD","RXL","BK4534","LU0098860793.USD","LU2361045086.USD","SG9999002232.USD","LU1032466523.USD","JDOC","LU2125909247.SGD","IE00BLSP4452.SGD","LU0689626769.HKD","LU2361044949.HKD","LU1035773651.USD","LU2468319806.SGD","LU1023059063.AUD","SG9999013999.USD","LU1093756325.SGD","LU1929549753.HKD","LU1934455863.HKD","LU0106261372.USD","SG9999015358.SGD","LU1116320737.USD","LU2461242641.AUD","SG9999015341.SGD","LU2106854487.HKD","IE00BBT3K403.USD","LU1923622614.USD","LU1699723380.USD","LU2125909593.SGD","SMMT","LU1066051811.HKD","LU0266013472.USD","VHT","LU0070302665.USD","LU2125154778.USD","LU1061106388.HKD","XLV","LU0211331839.USD","IE00BFTCPJ56.SGD","LU0477156953.USD","LU1162221912.USD","PPH","LU1989772840.SGD","BMED","LU1291159041.SGD","LU2125154935.USD","BK4559","LU1983299246.USD","LU0965509010.AUD","IE0002141913.USD","SG9999001176.USD","LU1037948541.HKD","LU0289739699.SGD","BK4139","LU1116320901.HKD","BK4533","IE00BLSP4239.USD","FTXH","LU0859254822.USD","LU1934455194.USD","LU0320765646.SGD","IE00BN8TJ469.HKD","LU0265550946.USD","SG9999014559.SGD","LU2491050071.SGD","IE00BSNM7G36.USD","LU0320765489.SGD","LU0432979614.USD","LU0238689110.USD","LU0203347892.USD","LU1066053197.SGD","MRK","LU0868494617.USD","LU1941712264.USD","LU2361044865.SGD","SGXZ57979304.SGD","LU0861579265.USD","SG9999014542.SGD","LU2357627491.SGD","LU2491050154.USD","LU1057294990.SGD","BK4007","LU1201861249.SGD","LU0965508806.USD","LU0965509283.SGD","LU1585245621.USD","BK4550","LU1571399168.USD","LU0234572021.USD","IE00BJT1NW94.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664803903","title":"Analysts’ Top Healthcare Picks: Align Tech (ALGN), Eledon Pharmaceuticals (ELDN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2664803903","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664803903?lang=en_us&edition=fundamental","pubTime":"2026-09-03 23:50","pubTimestamp":1788450609,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Align Tech (ALGN) and Eledon Pharmaceuticals (ELDN) ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-align-tech-algn-eledon-pharmaceuticals-eldn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-align-tech-algn-eledon-pharmaceuticals-eldn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","LU2023250504.SGD","ALGN","BK4137","LU2023250843.SGD","LU2106854487.HKD","LU1974910355.USD","LABU","ELDN","XLV","LU0029874061.USD","BK4198","BK4534","LU1917777945.USD","LU0128526141.USD","BK4588","BK4504","GLAM","XBI","BK4139","HCSG","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664080334","title":"Spire Healthcare grants Toscafund brief extension on potential 250p-per-share bid","url":"https://stock-news.laohu8.com/highlight/detail?id=2664080334","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664080334?lang=en_us&edition=fundamental","pubTime":"2026-09-03 23:32","pubTimestamp":1788449563,"startTime":"0","endTime":"0","summary":"Spire Healthcare ( ($GB:SPI) ) has provided an announcement. Spire Healthcare has disclosed that Toscafund Asset Management, its second-largest sha...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/spire-healthcare-grants-toscafund-brief-extension-on-potential-250p-per-share-bid?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/spire-healthcare-grants-toscafund-brief-extension-on-potential-250p-per-share-bid?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XBI","XLV","BK4585","BK4137","HCSG","LU0128526141.USD","BK4581","LU0029874061.USD","BK4588","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664808827","title":"Analysts’ Top Healthcare Picks: uniQure (QURE), Alumis Inc. (ALMS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2664808827","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664808827?lang=en_us&edition=fundamental","pubTime":"2026-09-03 22:30","pubTimestamp":1788445821,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on uniQure (QURE), Alumis Inc. (ALMS) and Omnicell (OMC...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-uniqure-qure-alumis-inc-alms-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-uniqure-qure-alumis-inc-alms-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BK4137","LABU","LU0889565916.HKD","LU0109394709.USD","LU0320765992.SGD","LU0029874061.USD","XLV","BK4585","BK4581","LU0128526141.USD","ALMS","BK4139","BK4588","XBI","QURE","HCSG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664704888","title":"Analysts Are Bullish on Top Healthcare Stocks: Revolution Medicines (RVMD), Teva Pharmaceutical (TEVA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2664704888","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664704888?lang=en_us&edition=fundamental","pubTime":"2026-09-03 22:10","pubTimestamp":1788444623,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Revolution Medicines (RVMD) and Teva Pharmaceutical ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-revolution-medicines-rvmd-teva-pharmaceutical-teva-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-revolution-medicines-rvmd-teva-pharmaceutical-teva-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00B2B36J28.USD","IE00B4R5TH58.HKD","BK4557","LU0029874061.USD","BK4581","RVMD","BK4559","IE0009355771.USD","BK4585","IDNA","BK4584","LU1983299246.USD","TEVA","BK4596","XBI","LU0320765992.SGD","HCSG","IE00BJT1NW94.SGD","LU0128526141.USD","LU2324357040.USD","BK4007","XLV","LABU","BK4139","CANC","IE0009354923.USD","BK4566","BK4588","LU0889565916.HKD","PTH","BBH","BK4137","IE0002141913.USD","LU0109394709.USD","IE00BJJMRZ35.SGD","IE00BFTCPJ56.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664870565","title":"AbbVie's Phase 3 Study of Etentamig in Multiple Myeloma Meets Dual Primary Endpoints","url":"https://stock-news.laohu8.com/highlight/detail?id=2664870565","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664870565?lang=en_us&edition=fundamental","pubTime":"2026-09-03 22:07","pubTimestamp":1788444473,"startTime":"0","endTime":"0","summary":"AbbVie's (ABBV) phase 3 study of etentamig in patients with triple-class exposed relapsed/refractory multiple myeloma met its dual primary endpoints of objective response rate and progression-free sur","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2129689514.USD","LU0965509010.AUD","SG9999003800.SGD","TRUH","LU0320765646.SGD","ABBV","LU0965509283.SGD","LU2433249047.HKD","SG9999015952.SGD","IE000WAW04H5.SGD","XLV","BK4581","LU0661504455.SGD","RXL","LU1718418525.SGD","IYH","LU1923622614.USD","IE00BJT1NW94.SGD","LU0289739343.SGD","LU0820561909.HKD","IE00BGHQF631.EUR","LU0289739699.SGD","LU1670628061.USD","SG9999001440.SGD","PJP","FHLC","IE0009355771.USD","LU0456855351.SGD","LU2237443549.SGD","LU2357627491.SGD","LU0256863902.USD","IE00BVYPNW00.USD","LU1267930490.SGD","IE00BBT3K403.USD","JDOC","LU1732799900.SGD","PPH","LU1057294990.SGD","SG9999015986.USD","MEDX","FTXH","LU2237443465.HKD","VHT","IE0004445239.USD","IE000SO60NU8.SGD","LU2089984988.USD","IXJ","AGNG","LU2468319806.SGD","GLAM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664587722","title":"AbbVie Says Blood Cancer Drug Met Dual Primary Endpoints in Phase 3 Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2664587722","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664587722?lang=en_us&edition=fundamental","pubTime":"2026-09-03 21:42","pubTimestamp":1788442920,"startTime":"0","endTime":"0","summary":"AbbVie said a drug to treat blood cancer met its dual primary endpoints in a phase 3 study.The company said etentamig demonstrated a significantly higher objective response rate and improvements in pr","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"AbbVie Says Blood Cancer Drug Met Dual Primary Endpoints in Phase 3 Study","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE000BZT7R73.USD","JDOC","LU0472753341.HKD","RXL","FHLC","IE00BLSP4452.SGD","LU0170899867.USD","SG9999001440.SGD","XLV","LU1003077747.HKD","LU0823416689.USD","IYH","IE00BBT3K403.USD","IE00B42XCP33.USD","BK4585","IE00B19Z3B42.SGD","LU2237443978.SGD","IE000F7OJYX1.SGD","PJP","LU0203347892.USD","LU0861579265.USD","LU0868494617.USD","LU1291159041.SGD","FTXH","LU1244550221.USD","LU2112291526.USD","LU1989771016.USD","LU2089283258.USD","LU1093756325.SGD","LU0211328371.USD","GLAM","ABBV","AGNG","TRUH","IE00BDGV0183.EUR","LU0124676726.USD","VHT","LU0868494708.USD","LU0098860793.USD","IE0000B7K699.USD","LU1551013342.USD","LU0256863902.USD","PPH","LU2129689431.USD","LU0289961442.SGD","IXJ","LU0859254822.USD","LU1732799900.SGD","MEDX","IE00BVYPNV92.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664877405","title":"J.P. Morgan’s Salveen Richter Reiterates Buy on Teva, Citing TEV-408 Phase 2a Success and Pipeline-in-a-Product Potential","url":"https://stock-news.laohu8.com/highlight/detail?id=2664877405","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664877405?lang=en_us&edition=fundamental","pubTime":"2026-09-03 21:25","pubTimestamp":1788441955,"startTime":"0","endTime":"0","summary":"Teva Pharmaceutical, the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Salveen Richter from Goldman Sachs ma...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/j-p-morgans-salveen-richter-reiterates-buy-on-teva-citing-tev-408-phase-2a-success-and-pipeline-in-a-product-potential-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/j-p-morgans-salveen-richter-reiterates-buy-on-teva-citing-tev-408-phase-2a-success-and-pipeline-in-a-product-potential-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1868836757.USD","LU2089283258.USD","LU2237443895.HKD","BK4516","LU2324357040.USD","LU1988902786.USD","IE0034235188.USD","LABU","XLV","XBI","LU0006306889.USD","TEVA","BK4566","LU2487616109.SGD","LU1989772923.USD","LU2237443465.HKD","LU1144417596.USD","LU1989772840.SGD","IE00BZ1G4Q59.USD","LU1791710582.SGD","LU2237438978.USD","LU1894683264.USD","BK4504","LU0912757837.SGD","IE0004091025.USD","LU1720051017.SGD","KBWB","LU0528227936.USD","LU1244550577.SGD","IE00BSNM7G36.USD","LU0345770993.USD","BK4581","LU0942090050.USD","IE0002270589.USD","IE00BKVL7J92.USD","GSX","LU0971096721.USD","LU0314104364.USD","LU2237443549.SGD","LU2265009873.SGD","BK4557","IAI","LU0882574139.USD","LU0210528500.USD","LU2471134879.HKD","BK4533","LU2264538146.SGD","LU2896262040.SGD","IE0004086264.USD","LU0096364046.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664587723","title":"AbbVie announces Phase 3 Cervino study met dual primary endpoints of ORR, PFS","url":"https://stock-news.laohu8.com/highlight/detail?id=2664587723","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664587723?lang=en_us&edition=fundamental","pubTime":"2026-09-03 21:25","pubTimestamp":1788441947,"startTime":"0","endTime":"0","summary":"AbbVie (ABBV) announced positive topline results from the Phase 3 Cervino study evaluating etentamig, an investigational BCMA x CD3 bispecific T-ce...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/abbvie-announces-phase-3-cervino-study-met-dual-primary-endpoints-of-orr-pfs-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/abbvie-announces-phase-3-cervino-study-met-dual-primary-endpoints-of-orr-pfs-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0124676726.USD","LU1496350171.SGD","LU0057025933.USD","LU1989772840.SGD","IE000WAW04H5.SGD","LU0417517546.SGD","LU1057294990.SGD","BK4550","TRUH","LU0965509283.SGD","GLAM","LU2237443465.HKD","ABBV","PPH","LU1929549753.HKD","IE000F7OJYX1.SGD","LU0868494617.USD","LU0820561909.HKD","LU0882574055.USD","LU2129689431.USD","BK4585","IE00BLSP4239.USD","LU1093756325.SGD","LU1244550494.USD","LU0795875169.SGD","AGNG","BK4559","JDOC","LU0942090050.USD","LU0203347892.USD","VHT","FTXH","LU2089284900.SGD","LU0320765646.SGD","PJP","RXL","LU0912757837.SGD","IYH","IXJ","IE0004445239.USD","IE00BJJMRZ35.SGD","LU0472753341.HKD","LU1585245621.USD","XLV","LU0256863811.USD","LU2357627491.SGD","FHLC","SG9999011175.SGD","ORR","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664877895","title":"AbbVie's Blood Cancer Drug Meets Late-Stage Trial Goals","url":"https://stock-news.laohu8.com/highlight/detail?id=2664877895","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664877895?lang=en_us&edition=fundamental","pubTime":"2026-09-03 21:18","pubTimestamp":1788441527,"startTime":"0","endTime":"0","summary":"AbbVie's blood cancer drug meets late-stage trial goalsSept 3 (Reuters)-AbbVieABBV.Nsaid on Thursday its drug for a type of blood cancer has met the main goals of a late-stage trial.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nL4N44V12L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JDOC","LU1934455277.USD","LU0098860793.USD","IXJ","LU0820561909.HKD","LU0057025933.USD","PJP","IE000MB6IJN5.SGD","LU0472753341.HKD","SG9999015945.SGD","IE00B3PB1722.GBP","TRUH","IE00BN8TJ469.HKD","LU0289961442.SGD","LU0256863902.USD","FTXH","LU1496350171.SGD","IE00BLSP4239.USD","GLAM","LU0820561818.USD","IE0009355771.USD","LU0203345920.USD","PPH","IE0004445239.USD","RXL","AGNG","XLV","LU0128525929.USD","FHLC","LU0942090050.USD","MEDX","LU1989772923.USD","LU0726765562.USD","IE00BBT3K403.USD","LU2089283258.USD","LU0211328371.USD","LU0985320562.USD","LU2112291526.USD","ABBV","SG9999015952.SGD","IYH","BK4585","LU0395794307.EUR","LU0114720955.EUR","VHT","LU1934455863.HKD","LU2357627491.SGD","SG9999001440.SGD","LU1585245621.USD","IE00BVYPNW00.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664887207","title":"Abbvie - Phase 3 Cervino Study Met Dual Primary Endpoints; Full Results to be Presented Sept 23-26","url":"https://stock-news.laohu8.com/highlight/detail?id=2664887207","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664887207?lang=en_us&edition=fundamental","pubTime":"2026-09-03 21:15","pubTimestamp":1788441300,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nTUA9C2QXL:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["VHT","LU1551013425.SGD","PJP","LU0114720955.EUR","IE00BBT3K403.USD","LU2347655073.USD","FHLC","GLAM","JDOC","LU0689472784.USD","LU1839511570.USD","LU2089984988.USD","LU0820561909.HKD","XLV","LU1291159041.SGD","LU1496350171.SGD","LU1267930573.SGD","LU0098860793.USD","IYH","TRUH","MEDX","LU0553294199.USD","LU1670628061.USD","LU0234572021.USD","LU1236620834.HKD","LU2087621335.USD","LU1244550221.USD","LU2133065610.SGD","IXJ","LU1023059063.AUD","ABBV","LU1718418525.SGD","LU1244550577.SGD","LU1585245621.USD","FTXH","LU2125909593.SGD","LU0122379950.USD","PPH","IE00BN8TJ469.HKD","LU0965509010.AUD","IE00B4R5TH58.HKD","LU1093756325.SGD","LU2237443549.SGD","LU1983299246.USD","LU1057294990.SGD","LU0859254822.USD","AGNG","RXL","BK4533","LU0511384066.AUD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664872073","title":"Abbvie - Etentamig Demonstrates Low Rates of Cytokine Release Syndrome and Fatal Infections","url":"https://stock-news.laohu8.com/highlight/detail?id=2664872073","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664872073?lang=en_us&edition=fundamental","pubTime":"2026-09-03 21:15","pubTimestamp":1788441300,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nTUA9C2QXL:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0943347566.SGD","PJP","IE00B3PB1722.GBP","LU0545039389.USD","LU1430594728.SGD","PPH","LU0859254822.USD","LU1244550577.SGD","LU0795875169.SGD","LU2089283258.USD","SG9999001440.SGD","FHLC","LU1732800096.USD","BK4588","IYH","LU2237443465.HKD","LU1244550494.USD","AGNG","JDOC","LU0170899867.USD","LU1989771016.USD","GLAM","IE00BBT3K403.USD","LU0128525929.USD","SG9999011175.SGD","VHT","LU0289961442.SGD","LU1934455194.USD","XLV","MEDX","IE00B19Z3B42.SGD","IE00B2B36J28.USD","LU2237443382.USD","SG9999003800.SGD","TRUH","LU0861579265.USD","LU1093756325.SGD","FTXH","SG9999015945.SGD","LU0942090050.USD","IXJ","LU1839511570.USD","LU0511384066.AUD","LU1934455863.HKD","RXL","ABBV","LU0456855351.SGD","LU0234572021.USD","IE000WAW04H5.SGD","LU2125909593.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664720768","title":"Abbvie - Etentamig Achieves 74% Orr and 60% Risk Reduction in Phase 3 Cervino Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2664720768","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664720768?lang=en_us&edition=fundamental","pubTime":"2026-09-03 21:15","pubTimestamp":1788441300,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nTUA9C2QXL:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00BJT1NW94.SGD","LU0861579265.USD","LU0545039389.USD","IE000MB6IJN5.SGD","LU0170899867.USD","LU0689472784.USD","LU0859254822.USD","ABBV","RXL","SG9999001440.SGD","BK4139","LU0417517546.SGD","BK4533","FTXH","LU1244550577.SGD","MEDX","LU0965508806.USD","PPH","TRUH","JDOC","LU1093756325.SGD","LU0882574055.USD","LU1670628061.USD","LU0289739343.SGD","LU2237443382.USD","LU1934455277.USD","LU0432979614.USD","BK4588","AGNG","VHT","IE000BZT7R73.USD","LU0795875169.SGD","LU0868494708.USD","FHLC","IE000SO60NU8.SGD","LU1929549753.HKD","LU1983299246.USD","SG9999011175.SGD","XLV","IXJ","IYH","LU1934455194.USD","IE00BJJMRZ35.SGD","LU1003077747.HKD","LU2133065610.SGD","GLAM","LU0726765562.USD","LU1236620834.HKD","PJP","LU0965509283.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664487207","title":"Abbvie Announces Positive Topline Results from the Phase 3 Cervino Trial Showing Etentamig Significantly Improved Response Rate and Progression-Free Survival in Patients with Relapsed/Refractory Multiple Myeloma","url":"https://stock-news.laohu8.com/highlight/detail?id=2664487207","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664487207?lang=en_us&edition=fundamental","pubTime":"2026-09-03 21:15","pubTimestamp":1788441300,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nTUA9C2QXL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TRUH","BK4139","LU1093756325.SGD","IYH","LU0310799852.SGD","LU0289961442.SGD","LU0310800379.SGD","IE000MB6IJN5.SGD","LU1670627923.USD","FHLC","VHT","JDOC","IE00BLSP4452.SGD","LU0820561909.HKD","LU0820561818.USD","IE0002141913.USD","LU1244550577.SGD","ABBV","LU1989772923.USD","XLV","IE000SO60NU8.SGD","LU2129689605.HKD","LU0432979614.USD","IXJ","LU0456855351.SGD","LU0203347892.USD","LU0198837287.USD","LU1244550221.USD","LU0511384066.AUD","PPH","GLAM","IE000F7OJYX1.SGD","LU0417517546.SGD","LU0128525929.USD","RXL","LU1934455863.HKD","LU2237443622.USD","LU0965508806.USD","BK4533","LU0965509010.AUD","IE000BZT7R73.USD","LU1244550494.USD","MEDX","PJP","LU2357627491.SGD","IE0004445239.USD","AGNG","FTXH","IE00B4R5TH58.HKD","LU1923622614.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":27,"pageCount":23,"totalSize":522,"code":"91000000","status":"200"}]}}